Skip to main content
The Journal of Spinal Cord Medicine logoLink to The Journal of Spinal Cord Medicine
. 2014 Jan;37(1):114–116. doi: 10.1179/2045772312Y.0000000089

Salmonella prostatitis in a man with spinal cord injury

Jörg Krebs 1, Konrad Göcking 1, Jürgen Pannek 1,
PMCID: PMC4066545  PMID: 24090046

Abstract

Context

Prostatitis is a very unusual manifestation of Salmonella urinary tract infection and has not been reported in men with spinal cord injury (SCI).

Findings

A 57-year-old man with paraplegia and a history of recurrent symptomatic urinary tract infections presented with Salmonella typhimurium prostatitis. Clinical and sonographic examination of the urinary tract, as well as urinalysis including microbiologic examination, revealed no relevant abnormalities. The microbiologic analysis of the ejaculate revealed growth of monophasic Salmonella enterica ssp. enterica serotype 4,12:i:-. A 6-week course of antibiotic treatment was initiated. There were no recurrent symptomatic urinary tract infections during follow-up.

Conclusion

Salmonellosis is a reportable disease and carriers have to refrain from activities in the food sector. Therefore, Salmonella prostatitis should be considered and excluded in men with SCI and a history of recurrent urinary tract infection who use intermittent catheterization for bladder management.

Keywords: Ciprofloxacin, Fluoroquinolones, Prostatitis, Salmonella, Salmonella typhimurium, Spinal cord injuries, Urinary tract infection, Intermittent bladder catheterization

Introduction

Prostatitis is a common urological disorder, with a prevalence ranging from 2 to 10%.1 However, bacterial infections of the prostate account for only approximately 10% of all prostatitis cases.2 In men with spinal cord injury (SCI), the rate of bacterial prostate infections seems to be considerably higher (33.3%).3 However, there are no epidemiologic reports on the incidence or prevalence of bacterial prostatitis in men with SCI.

The most commonly isolated bacteria in acute and chronic prostatitis are Escherichia coli, Klebsiella spp., Proteus spp., Enterococci spp., and Pseudomonas aeruginosa.46 We present a unique case of Salmonella typhimurium prostatitis in a man with SCI.

Case report

A 57-year-old man with neurogenic lower urinary tract dysfunction as a result of post-traumatic complete SCI at T6 40 years ago presented for a routine urologic check-up. The patient reported a history of recurrent urinary tract infections (UTIs) since he had started to use intermittent catheterization for bladder evacuation 6 years ago. Disinfection of the glans penis, use of a prehydrated hydrophilic catheter, and oral vaccination with an E. coli extract were unsuccessful in preventing recurrent UTIs (2–3 episodes/year). Two years ago, he had been diagnosed with symptomatic and febrile UTIs caused by Enterococcus and Streptococcus viridans and prostatitis caused by E. coli. (ejaculate culture). He was treated with ciprofloxacin for 6 weeks. Furthermore, long-term treatment with an alpha-1 antagonist (tamsulosin) had been initiated.

The patient reported performing clean intermittent catheterization five times daily after hand-washing and disinfection of the glans using a single-use hydrophilic catheter. He reported no urinary incontinence and no recent episodes of diarrhea. Bowel management consisted of digitally evacuation two to three times a week.

Physical examination revealed no signs of infection. Rectal examination of the prostate was unremarkable, apart from age-appropriate enlargement. Prostate, bladder, urethra, and kidneys appeared normal on sonographic examination. The video-urodynamic evaluation revealed an increased bladder capacity with neurogenic detrusor acontractility and reduced bladder sensation. No prostatic influx was observed. Urinalysis was normal, with no pathogenic bacteria detected. The serum level of prostate-specific antigen (PSA) (2.56 ng/ml) was within physiologic limits (0.27–3.42 ng/ml). The patient was HIV seronegative. Microbiologic analysis (National Center for Enteropathogenic Bacteria) of the ejaculate revealed growth of monophasic Salmonella enterica ssp. enterica serotype 4,12:i:-. Six weeks of antibiotic treatment (ciprofloxacin 500 mg twice daily) was initiated in accordance with the resistance testing. There were no recurrent symptomatic UTIs during follow-up.

Discussion

This is the first report of Salmonella prostatitis in a man with SCI. Reports of Salmonella prostatitis are exceedingly rare. Saphra and Winter7 have reported 49 UTIs (0.5%) from 9284 clinical and subclinical human Salmonella infections diagnosed at the New York Salmonella Center from 1939 through 1955. The prostate was involved in only “some” cases. Furthermore, a few case reports of Salmonella prostatitis have been published.813 In addition, the potential of prostate Salmonella infections in men with HIV infection and has been mentioned in the literature without reports of any confirmed cases.14,15

The route of infection remains unclear in this case. In general, Salmonella UTI may be the result of hematogenous spread or an ascending infection from a contaminated perineal area in carriers of Salmonella.16,17 Furthermore, certain sexual practices9 or urinary catheterization17,18 may facilitate Salmonella UTI by direct introduction of the pathogen into the urinary tract. Hematogenous spread is most likely in patients with predisposing conditions, e.g. chronic disease or immunosuppression.16,1921 This patient presented with no predisposing conditions. Furthermore, bacteremia with no symptoms of gastroenteritis is not very common with S. typhimurium.22 An ascending infection from a contaminated perineal area is unlikely in adults.9,23 Furthermore, this patient has not reported any recent episodes of diarrhea. A direct (venereal) introduction of Salmonella into the urogenital tract has been reported in a homosexual man.9 This patient has sexual dysfunction secondary to SCI and does not engage in sexual intercourse. However, he does perform intermittent catheterization for bladder evacuation. We therefore hypothesize that Salmonellae were introduced into the urinary tract via the urinary catheter.

Non-typhoid Salmonella UTI, most commonly presenting as cystitis or pyelonephritis, is rare but well documented.16,1921 Even though the most common clinical presentation of a non-typhoid Salmonella infection is gastroenteritis,19 the majority of patients with non-typhoid Salmonella UTI present with no gastrointestinal symptoms,16,20 and stool cultures are not positive in all patients.8,20 The reported proportion of patients with preceding diarrhea ranges from 1020 to 32%.16 This patient did not report any recent episodes of diarrhea. However, stool was not submitted for microbiologic analysis.

Prostatitis caused by S. typhimurium, as in this case, has also been reported by other authors.11,12 Salmonella species isolated in other prostatitis cases include Salmonella St. Paul,10 Salmonella enteritidis,9 Salmonella panama,8 and Salmonella paratyphoid.13 However, E. coli, Klebsiella spp., Proteus spp., Enterococci spp., and Pseudomonas spp., the most common pathogens in UTIs in SCI,24,25 are typically isolated in prostatitic infections.46,26

Apart from clinical signs and findings, microbiologic examination is the cornerstone of making the diagnosis of bacterial prostatitis. Most commonly, urine samples taken before and after prostate massage are submitted to microbiologic examination (two-glass test).27 However, prostate massage is contraindicated in acute prostatitis because of the risk of causing severe pain and bacterial dissemination.14,28 These risks can be avoided by examining an ejaculate sample instead of the post-massage sample. Furthermore, this alternative two-glass test has been reported to be more sensitive than the standard one.29 The determination of PSA serum levels is neither sensitive nor specific. Elevated PSA levels have been observed in approximately 60 and 20% of patients with acute and chronic, bacterial prostatitis, respectively.26 In this patient, PSA levels were within physiologic limits.

In this case, Salmonella prostatitis was treated with ciprofloxacin for 6 weeks according to the guidelines of the European Association of Urology.30 Fluoroquinolones, among which ciprofloxacin and levofloxacin are most widely used, are the first-line treatment in bacterial prostatitis, because they penetrate well into prostatic tissue and achieve good tissue levels.26,31 Approximately 10% of Enterobacteriaceae isolates are resistant to ciprofloxacin.18 The patients with Salmonella prostatitis reported in the literature had been treated with trimethoprim-sulfamethoxazole810 or nalidixic acid12 for 3–7 weeks and became asymptomatic with no recurrences. Adding an alpha-1 antagonist to the antibiotic therapy of prostatitis has been reported to significantly improve clinical and microbiologic outcomes as well as decrease recurrence.32,33 The evaluation of treatment success is usually based on the subsidence of symptoms, because there is no validated test of cure for bacterial prostatitis.26 The recurrence of UTIs is characteristic for chronic bacterial prostatitis,28 because the prostate serves as a reservoir for uropathogens. In our patient, there were no recurrent symptomatic UTI during the follow-up.

Conclusion

In conclusion, prostatitis is a very unusual manifestation of Salmonella UTI, but should be considered in men with SCI have a history of recurrent urinary tract infections and who void by intermittent catheterization. As Salmonellosis is a reportable disease and carriers have to refrain from activities in the food sector, detecting Salmonella infections (e.g. Salmonella prostatitis) is relevant.

References

  • 1.Krieger JN, Lee SW, Jeon J, Cheah PY, Liong ML, Riley DE. Epidemiology of prostatitis. Int J Antimicrob Agents 2008;31(Suppl. 1):S85–90 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.de la Rosette JJ, Hubregtse MR, Meuleman EJ, Stolk-Engelaar MV, Debruyne FM. Diagnosis and treatment of 409 patients with prostatitis syndromes. Urology 1993;41(4):301–7 [DOI] [PubMed] [Google Scholar]
  • 3.Perrouin-Verbe B, Labat JJ, Richard I, Mauduyt de la Greve I, Buzelin JM, Mathe JF. Clean intermittent catheterisation from the acute period in spinal cord injury patients. Long term evaluation of urethral and genital tolerance. Paraplegia 1995;33(11):619–24 [DOI] [PubMed] [Google Scholar]
  • 4.Cai T, Mazzoli S, Meacci F, Boddi V, Mondaini N, Malossini G, et al. Epidemiological features and resistance pattern in uropathogens isolated from chronic bacterial prostatitis. J Microbiol 2011;49(3):448–54 [DOI] [PubMed] [Google Scholar]
  • 5.Etienne M, Chavanet P, Sibert L, Michel F, Levesque H, Lorcerie B, et al. Acute bacterial prostatitis: heterogeneity in diagnostic criteria and management. Retrospective multicentric analysis of 371 patients diagnosed with acute prostatitis. BMC Infect Dis 2008;8:1–9 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Millan-Rodriguez F, Palou J, Bujons-Tur A, Musquera-Felip M, Sevilla-Cecilia C, Serrallach-Orejas M, et al. Acute bacterial prostatitis: two different sub-categories according to a previous manipulation of the lower urinary tract. World J Urol 2006;24(1):45–50 [DOI] [PubMed] [Google Scholar]
  • 7.Saphra I, Winter JW. Clinical manifestations of salmonellosis in man; an evaluation of 7779 human infections identified at the New York Salmonella Center. N Engl J Med 1957;256(24):1128–34 [DOI] [PubMed] [Google Scholar]
  • 8.Gerridzen RG, Ooi TC, McKendry JB. Salmonella epididymitis with recurrent septicemia in diabetic patient. Urology 1981;17(2):172–4 [DOI] [PubMed] [Google Scholar]
  • 9.Greene JB, Adler M, Holzman RS. Salmonella enteritidis genitourinary tract infection in a homosexual man. J Urol 1982;128(5):1046–8 [DOI] [PubMed] [Google Scholar]
  • 10.Young DV, Poretz DM. Treatment of Salmonella prostatitis with trimethoprim-sulfamethoxazole. South Med J 1978;71(6):742–3 [DOI] [PubMed] [Google Scholar]
  • 11.Melzer M, Altmann G, Rakowszczyk M. Urinary tract infections due to Salmonella. Harefuah 1963;65:395–9 [PubMed] [Google Scholar]
  • 12.Sumii T, Nakano H, Ohnishi Y, Kanamoto Y, Nishio T. A case of Salmonella prostatitis in a renal transplant patient. Kansenshogaku Zasshi 1986;60(6):624–6 [DOI] [PubMed] [Google Scholar]
  • 13.Laval E, Frick P. Paratyphoid fever B and prostatitis. Rev med Chile 1972;100(1):44–5 [PubMed] [Google Scholar]
  • 14.Brede CM, Shoskes DA. The etiology and management of acute prostatitis. Nat Rev Urol 2011;8(4):207–12 [DOI] [PubMed] [Google Scholar]
  • 15.Hyun G, Lowe FC. AIDS and the urologist. Urol Clin North Am 2003;30(1):101–9 [DOI] [PubMed] [Google Scholar]
  • 16.Tena D, Gonzalez-Praetorius A, Bisquert J. Urinary tract infection due to non-typhoidal Salmonella: report of 19 cases. J Infect 2007;54(3):245–9 [DOI] [PubMed] [Google Scholar]
  • 17.Mitchell RG Urinary tract infections caused by Salmonellae. Lancet 1965;1(7395):1092–3 [DOI] [PubMed] [Google Scholar]
  • 18.Ko MC, Liu CK, Woung LC, Lee WK, Jeng HS, Lu SH, et al. Species and antimicrobial resistance of uropathogens isolated from patients with urinary catheter. Tohoku J Exp Med 2008;214(4):311–9 [DOI] [PubMed] [Google Scholar]
  • 19.Cohen JI, Bartlett JA, Corey GR. Extra-intestinal manifestations of salmonella infections. Medicine (Baltimore) 1987;66(5):349–88 [DOI] [PubMed] [Google Scholar]
  • 20.Allerberger FJ, Dierich MP, Ebner A, Keating MR, Steckelberg JM, Yu PK, et al. Urinary tract infection caused by nontyphoidal Salmonella: report of 30 cases. Urol Int 1992;48(4):395–400 [DOI] [PubMed] [Google Scholar]
  • 21.Ramos JM, Aguado JM, Garcia-Corbeira P, Ales JM, Soriano F. Clinical spectrum of urinary tract infections due on nontyphoidal Salmonella species. Clin Infect Dis 1996;23(2):388–90 [DOI] [PubMed] [Google Scholar]
  • 22.Goyal A, Sooch N, Gupta MK. Occurrence of unusual manifestations and uncommon serotypes of Salmonella in human infection. J Commun Dis 1988;20(2):141–6 [PubMed] [Google Scholar]
  • 23.Wilson R, Feldman RA. Salmonella isolates from urine in the United States, 1968–1979. J Infect Dis 1982;146(2):293–6 [DOI] [PubMed] [Google Scholar]
  • 24.Penders J, Huylenbroeck AA, Everaert K, Van Laere M, Verschraegen GL. Urinary infections in patients with spinal cord injury. Spinal Cord 2003;41(10):549–52 [DOI] [PubMed] [Google Scholar]
  • 25.Faarvang KL, Muller P, Lomberg B, Biering-Sorensen F. Screening for bacteriuria in patients with spinal cord lesion: dipstick test, microscopic examination and urine culture. Spinal Cord 2000;38(2):106–8 [DOI] [PubMed] [Google Scholar]
  • 26.Lipsky BA, Byren I, Hoey CT. Treatment of bacterial prostatitis. Clin Infect Dis 2010;50(12):1641–52 [DOI] [PubMed] [Google Scholar]
  • 27.Nickel JC The Pre and Post Massage Test (PPMT): a simple screen for prostatitis. Tech Urol 1997;3(1):38–43 [PubMed] [Google Scholar]
  • 28.Murphy AB, Macejko A, Taylor A, Nadler RB. Chronic prostatitis: management strategies. Drugs 2009;69(1):71–84 [DOI] [PubMed] [Google Scholar]
  • 29.Budia A, Luis Palmero J, Broseta E, Tejadillos S, Benedicto A, Queipo JA, et al. Value of semen culture in the diagnosis of chronic bacterial prostatitis: a simplified method. Scand J Urol Nephrol 2006;40(4):326–31 [DOI] [PubMed] [Google Scholar]
  • 30.Naber KG, Bergman B, Bishop MC, Bjerklund-Johansen TE, Botto H, Lobel B, et al. EAU guidelines for the management of urinary and male genital tract infections. Urinary Tract Infection (UTI) Working Group of the Health Care Office (HCO) of the European Association of Urology (EAU). Eur Urol 2001;40(5):576–88 [DOI] [PubMed] [Google Scholar]
  • 31.Lugg J, Lettieri J, Stass H, Agarwal V. Determination of the concentration of ciprofloxacin in prostate tissue following administration of a single, 1000 mg, extended-release dose. J Chemother 2008;20(2):213–8 [DOI] [PubMed] [Google Scholar]
  • 32.Barbalias GA, Nikiforidis G, Liatsikos EN. Alpha-blockers for the treatment of chronic prostatitis in combination with antibiotics. J Urol 1998;159(3):883–7 [PubMed] [Google Scholar]
  • 33.Jeong CW, Lim DJ, Son H, Lee SE, Jeong H. Treatment for chronic prostatitis/chronic pelvic pain syndrome: levofloxacin, doxazosin and their combination. Urol Int 2008;80(2):157–61 [DOI] [PubMed] [Google Scholar]

Articles from The Journal of Spinal Cord Medicine are provided here courtesy of Taylor & Francis

RESOURCES